1. Ma, Xiaowu, Zhuang, Hongkai, Wang, Qingbin, Chen, Yajin, Shang, Changzhen. 2022. SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression. In Journal of hepatocellular carcinoma, 9, 83-98. doi:10.2147/JHC.S349966. https://pubmed.ncbi.nlm.nih.gov/35211427/
2. Zhang, Qinglin, Pan, Jiadong, An, Fangmei, Nie, He, Zhan, Qiang. . Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma. In Bioengineered, 12, 8147-8156. doi:10.1080/21655979.2021.1987131. https://pubmed.ncbi.nlm.nih.gov/34615436/
3. Lv, Hao, Sun, Yujie, Zhang, Yuchen. 2015. MiR-133 is Involved in Estrogen Deficiency-Induced Osteoporosis through Modulating Osteogenic Differentiation of Mesenchymal Stem Cells. In Medical science monitor : international medical journal of experimental and clinical research, 21, 1527-34. doi:10.12659/MSM.894323. https://pubmed.ncbi.nlm.nih.gov/26013661/
4. Tang, Peifu, Xiong, Qi, Ge, Wei, Zhang, Lihai. . The role of microRNAs in osteoclasts and osteoporosis. In RNA biology, 11, 1355-63. doi:10.1080/15476286.2014.996462. https://pubmed.ncbi.nlm.nih.gov/25692234/
5. Bhutia, Yangzom D, Babu, Ellappan, Ramachandran, Sabarish, Thangaraju, Muthusamy, Ganapathy, Vadivel. . SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms. In The Biochemical journal, 473, 1113-24. doi:10.1042/BJ20150751. https://pubmed.ncbi.nlm.nih.gov/27118869/
6. Zhang, Xu-Dong, Liu, Zhong-Yuan, Luo, Kai, Huang, Shuai, Li, Ren-Feng. 2023. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis. In Scientific reports, 13, 16859. doi:10.1038/s41598-023-43699-2. https://pubmed.ncbi.nlm.nih.gov/37803063/